Duke-NUS Medical School is launching a $20 million incubator, LIVE Ventures, to help commercialize academic research projects and transform scientific breakthroughs into clinical applications.
The incubator aims to supply academic innovators with expertise and resources from the public and private sectors – including pharmaceutical companies, market data research professionals, investors, and...
TIIM Healthcare, an AI health technology company in Singapore, has received an exclusive IP license to commercialise a novel technology developed by the Duke-NUS Medical School to identify patients at risk of dying from sepsis.
Established in 2016, TIIM, which stands for Technology Innovation in Medicine, develops AI triaging solutions. Its flagship product, aiTRIAGE, incorporates both heart rate...
